LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple-drug attack targets rare, aggressive neuroendocrine cancers
Disease control Not yet recruitingThis study tests a combination of three drugs (benmelstobart, anlotinib, and chemotherapy) as the first treatment for people with a rare and fast-growing type of cancer called large-cell neuroendocrine carcinoma of the lung or similar cancers outside the lung. The goal is to see …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for rare lung cancer: drug combo targets tough tumors
Disease control Not yet recruitingThis study tests whether adding a new drug called obrixtamig to standard chemotherapy can help people with advanced large-cell neuroendocrine carcinoma of the lung, a rare and aggressive cancer. About 75 adults who have already started one round of chemo will receive the combinat…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated May 22, 2026 14:03 UTC